{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/erectile-dysfunction/background-information/risk-factors/","result":{"pageContext":{"chapter":{"id":"1e4fb7fb-80f2-58a9-9f0a-cd2a06bd58f5","slug":"risk-factors","fullItemName":"Risk factors","depth":2,"htmlHeader":"<!-- begin field cebbf2d4-4e1b-4c85-9075-a86500be81f8 --><h2>What are the risk factors?</h2><!-- end field cebbf2d4-4e1b-4c85-9075-a86500be81f8 -->","summary":"","htmlStringContent":"<!-- begin item ece9a2f6-a6b9-4fba-935b-a86500be7c7a --><!-- begin field 07ec64a8-972d-48a1-906c-a86500be81f8 --><ul><li><strong>The risk factors for erectile dysfunction are similar to those for CVD and include </strong>obesity, diabetes mellitus, dyslipidaemia, metabolic syndrome, hypertension, endothelial dysfunction, and lifestyle factors (such as lack of exercise and smoking) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/erectile-dysfunction/references/\">Nehra et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/erectile-dysfunction/references/\">BSSM, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/erectile-dysfunction/references/\">Gandaglia et al, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/erectile-dysfunction/references/\">Muneer, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/erectile-dysfunction/references/\">Rajendran, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/erectile-dysfunction/references/\">Randrup, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/erectile-dysfunction/references/\">Binmoammar et al, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/erectile-dysfunction/references/\">BMJ, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/erectile-dysfunction/references/\">European Association of Urology, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/erectile-dysfunction/references/\">Kouidrat et al, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/erectile-dysfunction/references/\">Raheem et al, 2017</a>]:<ul><li>The link between erectile dysfunction and CVD probably involves endothelial dysfunction and small vessel atherosclerosis, resulting in disorders of penile and coronary circulation. Since penile arteries are smaller than coronary arteries, the same level of endothelial dysfunction causes a more significant reduction of blood flow in erectile tissues compared with that in coronary circulation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/erectile-dysfunction/references/\">Gandaglia et al, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/erectile-dysfunction/references/\">Muneer, 2014</a>].</li><li>Erectile dysfunction not only shares risk factors with CVD but is also, in itself, an independent marker of increased risk for CVD. The increased risk is probably independent of conventional cardiovascular risk factors (such as age, weight, hypertension, diabetes, hyperlipidaemia, and cigarette smoking) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/erectile-dysfunction/references/\">Gupta, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/erectile-dysfunction/references/\">Fang, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/erectile-dysfunction/references/\">European Association of Urology, 2017</a>].</li><li>Erectile dysfunction is also a marker of significantly increased risk of coronary artery disease (CAD), stroke, and all-cause mortality. This could be because these conditions share the same risk factors and pathophysiological mechanisms, such as endothelial dysfunction and chronic inflammation, vascular structural alterations, dysfunctional nitrous oxide pathways, and abnormal peripheral sympathetic activity [<a class=\"bibliography-reference internal-reference\" href=\"/topics/erectile-dysfunction/references/\">Rajendran, 2014</a>].</li></ul></li><li>There is also some evidence for an association between erectile dysfunction and psoriasis, ankylosing spondylitis, non-alcoholic fatty liver, and transrectal ultrasound (TRUS)-guided prostate biopsy<strong> </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/erectile-dysfunction/references/\">European Association of Urology, 2017</a>]. There is some evidence that long-distance cycling (for example more than 3 hours a week) can cause erectile dysfunction, possibly due to nerve damage caused by contact with the saddle [<a class=\"bibliography-reference internal-reference\" href=\"/topics/erectile-dysfunction/references/\">Muneer, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/erectile-dysfunction/references/\">BMJ, 2017</a>], but further research is needed to confirm this [<a class=\"bibliography-reference internal-reference\" href=\"/topics/erectile-dysfunction/references/\">Michiels, 2015</a>].</li></ul><!-- end field 07ec64a8-972d-48a1-906c-a86500be81f8 --><!-- end item ece9a2f6-a6b9-4fba-935b-a86500be7c7a -->","topic":{"id":"5bdc98b8-cec1-551c-a1ea-d279c1d4a789","topicId":"a255a0a6-1216-4961-a8d2-0841d9ddf8fe","topicName":"Erectile dysfunction","slug":"erectile-dysfunction","lastRevised":"Last revised in July 2020","chapters":[{"id":"60de3c56-e8f8-5ed1-af6c-079fbfc5297a","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"1390eb84-15de-5511-a888-7aa10c5f380e","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"6f0e3524-4bd9-524b-b0c7-5df8463a2632","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"6f8d7396-341b-5cdb-9ab7-11d371aecf1b","slug":"changes","fullItemName":"Changes"},{"id":"7273623f-46a6-55a9-b20f-3174d857bb0b","slug":"update","fullItemName":"Update"}]},{"id":"954f3dd9-902d-5807-89cb-b68e9a352975","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"4dbc024b-ad9c-5c73-975f-44d47f56c8db","slug":"goals","fullItemName":"Goals"},{"id":"3c8ab157-63cf-5e79-95c8-8d533751d80b","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c87478c5-0e05-5e5e-aff4-92c6bd965c7e","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"7aad46cb-3cd1-586a-9eb7-5b41fb304896","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"792aba04-631e-555e-8bf8-2c58ec675d8d","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"19da5bcc-2817-5766-9335-d7974d14f3c4","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"9a1a9a32-e4af-5cb5-83a9-c382b1ee5d40","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"ecd0b9da-d509-587d-9c32-4e2828d198af","slug":"definition","fullItemName":"Definition"},{"id":"a0eac8e3-a0a4-5026-870e-24f5a5597b63","slug":"causes","fullItemName":"Causes"},{"id":"1e4fb7fb-80f2-58a9-9f0a-cd2a06bd58f5","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"8f1a78ac-cb2e-5627-aaf2-9eddf7d19863","slug":"prevalence","fullItemName":"Prevalence"},{"id":"fd7eccbd-c104-54ec-aa7e-7b5d8c806ded","slug":"prognosis","fullItemName":"Prognosis"},{"id":"3dbe567c-f646-542c-a649-49c5e0a2e1d8","slug":"complications","fullItemName":"Complications"}]},{"id":"a7b9bdc4-1390-5184-aa4d-a331be735168","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"bdb32096-c2e0-55ac-b935-a61204406095","slug":"assessment","fullItemName":"Assessment"}]},{"id":"7b089806-f4ac-58ac-a788-629e509b4868","fullItemName":"Management","slug":"management","subChapters":[{"id":"09f9cf76-1bbb-5d37-8bf8-9ed3fd4a9b64","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"92e38517-29a0-5e5f-8e17-2959aa09e71a","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"0d5ad6d5-d065-5eb5-99c8-b654497d8d19","slug":"phosphodiesterase-5-pde-5-inhibitors","fullItemName":"Phosphodiesterase-5 (PDE-5) inhibitors"}]},{"id":"f021401a-d917-5e2c-b234-816a1108de92","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"c0f733e9-9f61-5807-8fce-90a6aba44893","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"ab85ccb2-6023-521d-b0ed-2cf9647aff63","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"536d66ad-375a-52d4-a2ee-1dfc1ec8a13e","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d1ea3b0d-cce2-5191-82e1-3149d32c0296","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"c69a15f7-87a5-5513-b5d1-b21a85dd1561","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"1d54146b-d6e9-54f2-885a-74200666af7c","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"04d092eb-cbf9-5bce-9d0d-65e9e5d6ba1b","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"9a1a9a32-e4af-5cb5-83a9-c382b1ee5d40","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}